Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Aurora kinase A controls meiosis I progression in mouse oocytes

A Saskova, P Solc, V Baran, M Kubelka, RM Schultz, J Motlik

. 2008 ; 7 (15) : 2368-2376.

Jazyk angličtina Země Spojené státy americké

Perzistentní odkaz   https://www.medvik.cz/link/bmc11004932
E-zdroje

NLK Free Medical Journals od 2002 do Před 1 rokem

Aurora kinase A (AURKA), which is a centrosome-localized serine/threonine kinase crucial for cell cycle control, is critically involved in centrosome maturation and spindle assembly in somatic cells. Active T288 phosphorylated AURKA localizes to the centrosome in the late G(2) and also spreads to the minus ends of mitotic spindle microtubules. AURKA activates centrosomal CDC25B and recruits cyclin B1 to centrosomes. We report here functions for AURKA in meiotic maturation of mouse oocytes, which is a model system to study the G(2) to M transition. Whereas AURKA is present throughout the entire GV-stage oocyte with a clear accumulation on microtubule organizing centers (MTOC), active AURKA becomes entirely localized to MTOCs shortly before germinal vesicle breakdown. In contrast to somatic cells in which active AURKA is present at the centrosomes and minus ends of microtubules, active AURKA is mainly located on MTOCs at metaphase I (MI) in oocytes. Inhibitor studies using Roscovitine (CDK1 inhibitor), LY-294002 (PI3K inhibitor) and SH-6 (PKB inhibitor) reveal that activation of AURKA localized on MTOCs is independent on PI3K-PKB and CDK1 signaling pathways and MOTC amplification is observed in roscovitine- and SH-6-treated oocytes that fail to undergo nuclear envelope breakdown. Moreover, microinjection of Aurka mRNA into GV-stage oocytes cultured in 3-isobutyl-1-methyl xanthine (IBMX)-containing medium to prevent maturation also results in MOTC amplification in the absence of CDK1 activation. Overexpression of AURKA also leads to formation of an abnormal MI spindle, whereas RNAi-mediated reduction of AURKA interferes with resumption of meiosis and spindle assembly. Results of these experiments indicate that AURKA is a critical MTOC-associated component involved in resumption of meiosis, MTOC multiplication, proper spindle formation and the metaphase I-metaphase II transition.

000      
04111naa 2200589 a 4500
001      
bmc11004932
003      
CZ-PrNML
005      
20121102100958.0
008      
110310s2008 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Šašková, Adéla. $7 xx0211174
245    10
$a Aurora kinase A controls meiosis I progression in mouse oocytes / $c A Saskova, P Solc, V Baran, M Kubelka, RM Schultz, J Motlik
314    __
$a Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Libechov, Czech Republic.
520    9_
$a Aurora kinase A (AURKA), which is a centrosome-localized serine/threonine kinase crucial for cell cycle control, is critically involved in centrosome maturation and spindle assembly in somatic cells. Active T288 phosphorylated AURKA localizes to the centrosome in the late G(2) and also spreads to the minus ends of mitotic spindle microtubules. AURKA activates centrosomal CDC25B and recruits cyclin B1 to centrosomes. We report here functions for AURKA in meiotic maturation of mouse oocytes, which is a model system to study the G(2) to M transition. Whereas AURKA is present throughout the entire GV-stage oocyte with a clear accumulation on microtubule organizing centers (MTOC), active AURKA becomes entirely localized to MTOCs shortly before germinal vesicle breakdown. In contrast to somatic cells in which active AURKA is present at the centrosomes and minus ends of microtubules, active AURKA is mainly located on MTOCs at metaphase I (MI) in oocytes. Inhibitor studies using Roscovitine (CDK1 inhibitor), LY-294002 (PI3K inhibitor) and SH-6 (PKB inhibitor) reveal that activation of AURKA localized on MTOCs is independent on PI3K-PKB and CDK1 signaling pathways and MOTC amplification is observed in roscovitine- and SH-6-treated oocytes that fail to undergo nuclear envelope breakdown. Moreover, microinjection of Aurka mRNA into GV-stage oocytes cultured in 3-isobutyl-1-methyl xanthine (IBMX)-containing medium to prevent maturation also results in MOTC amplification in the absence of CDK1 activation. Overexpression of AURKA also leads to formation of an abnormal MI spindle, whereas RNAi-mediated reduction of AURKA interferes with resumption of meiosis and spindle assembly. Results of these experiments indicate that AURKA is a critical MTOC-associated component involved in resumption of meiosis, MTOC multiplication, proper spindle formation and the metaphase I-metaphase II transition.
650    _2
$a zvířata $7 D000818
650    _2
$a blastodisk $x metabolismus $7 D054239
650    _2
$a buněčný cyklus $x fyziologie $x genetika $7 D002453
650    _2
$a cyklin-dependentní kinasy $x fyziologie $x metabolismus $7 D018844
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a HeLa buňky $7 D006367
650    _2
$a lidé $7 D006801
650    _2
$a meióza $x fyziologie $x genetika $7 D008540
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a organizační centrum mikrotubulů $x metabolismus $7 D022101
650    _2
$a aparát dělícího vřeténka $x metabolismus $7 D008941
650    _2
$a buňky NIH 3T3 $7 D041681
650    _2
$a oocyty $x enzymologie $x fyziologie $7 D009865
650    _2
$a Phosphatidylinositol 3-Kinases $x me [Metabolism]
650    _2
$a Phosphatidylinositol 3-Kinases $x ph [Physiology]
650    _2
$a vazba proteinů $7 D011485
650    _2
$a protein-serin-threoninkinasy $x fyziologie $x genetika $x metabolismus $7 D017346
650    _2
$a protoonkogenní proteiny c-akt $x fyziologie $x metabolismus $7 D051057
650    _2
$a financování organizované $7 D005381
700    1_
$a Šolc, Petr $7 xx0127216
700    1_
$a Baran, Vladimír $7 xx0121870
700    1_
$a Kubelka, Michal $7 xx0128660
700    1_
$a Schultz, Richard M. $7 xx0135899
700    1_
$a Motlík, Jan. $7 ola200208047
773    0_
$t Cell Cycle $w MED00173232 $g Roč. 7, č. 15 (2008), s. 2368-2376
910    __
$a ABA008 $b x $y 1
990    __
$a 20110412080905 $b ABA008
991    __
$a 20121102101004 $b ABA008
999    __
$a ok $b bmc $g 832848 $s 696972
BAS    __
$a 3
BMC    __
$a 2008 $b 7 $c 15 $d 2368-2376 $m Cell Cycle $n Cell Cycle $x MED00173232
LZP    __
$a 2011-4B/vtme

Najít záznam